FOXO4-DRI Research for Cellular Senescence
An evidence-based overview of research examining FOXO4-DRI in the context of cellular senescence. This page synthesizes findings from peer-reviewed literature.
Research Summary
FOXO4-DRI was designed to interfere with FOXO4-p53 signaling. The 2017 study reported senescent-cell apoptosis in experimental cell and mouse systems; a 2025 structural study mapped FOXO4-DRI binding to p53. These findings do not establish selective clearance or benefit in people.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.